Skip to main content
CriticalFDAfda-F-1577-2017OTHER

Xanthium & Siler Combo (Bi Yan Pian) DIETARY SUPPLEMENT, Net cont: 100 tablets (300mg each), Net Wt. 1.06oz (30g)

⚠ Critical Alert — Stop Using Immediately

This product has been flagged with severe risks (other). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.

Category
Units Affected
100
Recall Date
February 7, 2017
Issuing Agency
Hazard
Other

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1577-2017.

Presence of Ephedrae Herba (ma huang), a FDA Banned Ephedra Alkaloid

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1577-2017.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Kingsway Trading Inc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1577-2017.

Kingsway Trading Inc

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Kingsway Trading Inc Recall FAQ

Kingsway Trading Inc is the subject of a supplements safety report: Xanthium & Siler Combo (Bi Yan Pian) DIETARY SUPPLEMENT, Net cont: 100 tablets (300mg each), Net Wt. 1.06oz (30g). The notice was published on February 7, 2017 by the U.S. Food and Drug Administration (FDA). Approximately 100 units are potentially affected.